908 Devices Analyst Ratings
Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), Aurinia Pharmaceuticals (AUPH) and 908 Devices (MASS)
Stifel Nicolaus Remains a Buy on 908 Devices (MASS)
Stephens & Co. Reiterates Overweight on 908 Devices, Maintains $14 Price Target
908 Devices Analyst Ratings
908 Devices (MASS) Receives a Buy From SVB Securities
908 Devices Analyst Ratings
Stephens & Co. Initiates Coverage On 908 Devices With Overweight Rating, Announces Price Target of $14
Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), 908 Devices (MASS) and Privia Health Group (PRVA)
SVB Securities Sticks to Its Buy Rating for 908 Devices (MASS)
SVB Securities Adjusts 908 Devices' Price Target to $20 From $30, Keeps Outperform Rating
908 Devices Analyst Ratings
SVB Leerink Maintains Outperform on 908 Devices, Lowers Price Target to $20
SVB Securities Keeps Their Buy Rating on 908 Devices (MASS)
908 Devices Analyst Ratings
SVB Leerink Maintains Outperform on 908 Devices, Lowers Price Target to $25
SVB Securities Keeps Their Buy Rating on 908 Devices (MASS)